Short pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #12,901 to #12,950.
- (hist) Trophoblastic neoplasms [310 bytes]
- (hist) Univariate [310 bytes]
- (hist) Superior gluteal [310 bytes]
- (hist) Pudendal plexus [310 bytes]
- (hist) Sucrose gap [310 bytes]
- (hist) Amidinium [310 bytes]
- (hist) Calmodulin-binding proteins [310 bytes]
- (hist) Suprarenal [310 bytes]
- (hist) Auricular appendage [310 bytes]
- (hist) Hurthle cell carcinoma screening [310 bytes]
- (hist) Chondroma cost-effectiveness of therapy [310 bytes]
- (hist) Chondroma future or investigational therapies [310 bytes]
- (hist) Malignant rhabdoid tumour classification [310 bytes]
- (hist) Malignant rhabdoid tumour epidemiology and demographics [310 bytes]
- (hist) Malignant rhabdoid tumour causes [310 bytes]
- (hist) Malignant rhabdoid tumour differential diagnosis [310 bytes]
- (hist) Malignant rhabdoid tumour history and symptoms [310 bytes]
- (hist) Malignant rhabdoid tumour physical examination [310 bytes]
- (hist) Malignant rhabdoid tumour staging [310 bytes]
- (hist) Malignant rhabdoid tumour laboratory tests [310 bytes]
- (hist) Malignant rhabdoid tumour CT [310 bytes]
- (hist) Malignant rhabdoid tumour MRI [310 bytes]
- (hist) Malignant rhabdoid tumour echocardiography or ultrasound [310 bytes]
- (hist) Malignant rhabdoid tumour other imaging findings [310 bytes]
- (hist) Malignant rhabdoid tumour other diagnostic studies [310 bytes]
- (hist) Malignant rhabdoid tumour medical therapy [310 bytes]
- (hist) Malignant rhabdoid tumour surgery [310 bytes]
- (hist) Malignant rhabdoid tumour primary prevention [310 bytes]
- (hist) Malignant rhabdoid tumour secondary prevention [310 bytes]
- (hist) Malignant rhabdoid tumour cost-effectiveness of therapy [310 bytes]
- (hist) Malignant rhabdoid tumour future or investigational therapies [310 bytes]
- (hist) Tabes Dorsalis other imaging findings [310 bytes]
- (hist) Porphyria ultrasound [310 bytes]
- (hist) Ataxia telangiectasia cost-effectiveness of therapy [310 bytes]
- (hist) Ataxia telangiectasia future or investigational therapies [310 bytes]
- (hist) Cough secondary prevention [310 bytes]
- (hist) Bradycardia primary prevention [310 bytes]
- (hist) Hyperthyroidism natural history, complications and prognosis [310 bytes]
- (hist) Ataxia telangiectasia case study one [310 bytes]
- (hist) Splenomegaly cost-effectiveness of therapy [310 bytes]
- (hist) Splenomegaly future or investigational therapies [310 bytes]
- (hist) Splenomegaly case study one [310 bytes]
- (hist) Malignant rhabdoid tumour case study one [310 bytes]
- (hist) Hurthle cell carcinoma case study one [310 bytes]
- (hist) 21-Hydroxylase Deficiency historical perspective [310 bytes]
- (hist) 21-Hydroxylase Deficiency differential diagnosis [310 bytes]
- (hist) 21-Hydroxylase Deficiency risk factors [310 bytes]
- (hist) 21-Hydroxylase Deficiency laboratory findings [310 bytes]
- (hist) 21-Hydroxylase Deficiency genotyping [310 bytes]
- (hist) 21-Hydroxylase Deficiency pelvic x ray [310 bytes]